Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
July 26, 2022 08:00 ET
|
Virax Biolabs Group Limited
London, United Kingdom, July 26, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX
July 21, 2022 10:33 ET
|
Virax Biolabs Group Limited
London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering
July 20, 2022 20:20 ET
|
Virax Biolabs Group Limited
London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders
May 31, 2022 08:30 ET
|
Virax Biolabs Group Limited
London, United Kingdom, May 31, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”), an innovative biotechnology company focused on the prevention, detection, and...
Virax Biolabs Introduces New Board of Directors, Announces Members
May 17, 2022 09:00 ET
|
Virax Biolabs Group Limited
London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs...
Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research
May 09, 2022 09:01 ET
|
Virax Biolabs Group Limited
London, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs (“Virax” or the “Company”), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral...
Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer
April 28, 2022 08:00 ET
|
Virax Biolabs Group Limited
London, United Kingdom, April 28, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) is pleased to announce the appointment of Jason D. Davis to the role of Chief...